HbA1c Variability in Type II Diabetes

NCT02879409 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Metformin
DRUG: Gliclazide
DRUG: Sitagliptin
DRUG: Liraglutide
DRUG: Pioglitazone
DRUG: Dapagliflozin
DRUG: human insulin

Sponsor

Weill Cornell Medical College in Qatar

Collaborators

[object Object]
[object Object]
[object Object]